![]() |
|
|
Vol. 281, Issue 3, 1113-1119, 1997
Research Institute of Toxicology, Utrecht University, NL-3508 TD
Utrecht, The Netherlands (I.B., M.O.);
NV Organon, Oss, The Netherlands
(F.A.D.) and
Free University of Brussels, Belgium (P.V., G.V.)
Present
address: Department of Pharmacology, Duke University Medical Center,
Durham, USA (M.O.)
Displacement of muscarinic radioligands by the cholinesterase
inhibitors parathion, paraoxon, physostigmine and phenyl saligenin cyclic phosphate was examined in rat cortex and brain stem, human cortex and brain stem, and in Chinese hamster ovary (CHO) cells expressing human M2 or M4 muscarinic acetylcholine receptors. None of
the cholinesterase inhibitors tested significantly affected binding of
the antagonist [3H]-quinuclinidyl benzilate. However, the
agonist [3H]oxotremorine-methiodide
(3H]oxo-M) was displaced by all compounds tested in a
differential manner. Parathion only marginally displaced
[3H]oxo-M binding with pKi values
<5 in all tissue or cell types. In rat brain paraoxon, physostigmine
and phenyl saligenin cyclic phosphate displaced [3H]oxo-M
with pKi values of 7.5, 7.0 and 6.1, respectively. The cholinesterase inhibitors displaced
[3H]oxo-M in human brain at 15- to 250-fold higher
concentrations, that is with pKi values of 6.3, 4.6 and 4.2, respectively. Maximal displacement of
[3H]oxo-M varied between 25% and 95%, depending on the
species and the compound. Human receptors in brain and in CHO cells
were equally sensitive to displacement of [3H]oxo-M by
parathion, physostigmine and phenyl saligenin cyclic phosphate.
However, paraoxon displaced [3H]oxo-M at
35-fold lower
concentrations from human receptors in brain than in CHO cells. In
conclusion, the data show that cholinesterase inhibitors interfere with
agonist binding to muscarinic acetylcholine receptors. The
species-selectivity of the displacement appears to result from
differences between rat and human muscarinic acetylcholine receptors.
In addition, for paraoxon marked differences exist between the
sensitivity of human muscarinic acetylcholine receptors in brain tissue
and of those expressed in clonal CHO cells.